Centro Médico Teknon
The cost of Ocrevus (ocrelizumab) treatment in Spain typically ranges from $25,000 to $40,000. Pricing can vary depending on the clinic, whether you need an initial or maintenance infusion, and the physician’s experience with multiple sclerosis care. In the United States, the average cost is $80,000 (per MSAA). That means Ocrevus in Spain is about 59% less than in the U.S.
Spanish clinics usually include the medication, infusion sessions, pre-infusion lab tests, physician monitoring, and follow-up visits. In the U.S., the drug cost is often listed separately from infusion fees, pre-treatment labs, and follow-up appointments. Always confirm exactly what’s included with your clinic or hospital.
Why do patients choose Spain for Ocrevus (ocrelizumab) treatment?
Access advanced Ocrevus (ocrelizumab) solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Ocrevus (ocrelizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ocrevus (ocrelizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ocrevus (ocrelizumab) journey.
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Ocrevus (ocrelizumab) Infusion
Week 1-2: Post-Operation
Week 3-4: Rehabilitation
Please note that each patient"s experience with Ocrevus (ocrelizumab) can differ. Always consult with your healthcare team for personalized advice.
Principal investigator in 100+ clinical trials for neurological treatments, including Ocrevus studies. Dr. Arroyo leads Quironsalud Madrid's Neurology Department.
Dr Romero Imbroda leads the Neurology Unit at Quirónsalud Marbella, specializing in multiple sclerosis treatments like Ocrevus. His research includes cutting-edge therapies for MS.
A pioneer in movement disorders with 40+ years of experience, Dr. Obeso leads the HM CINAC Integral Neurosciences Centre in Madrid.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.